Flamma SpA, a CDMO that develops, manufactures, and commercializes small molecule APIs for the pharmaceutical industry, has completed the construction of its first cGMP Kilo Lab at its Chignolo D’Isola headquarters in Italy.
 
The cGMP Kilo Lab is currently being used for an internal Flamma project in conjunction with its Flow Chemistry Pilot Unit. Customers with projects are reserving production slots for later in 2019. 
 
This investment is part of the Flamma 2020 Plan to bring improvement across its network of manufacturing sites. This Chignolo site adds another option when working with Flamma’s API site. 
 
GianMarco Negrisoli, corporate development manager at Flamma and chief executive officer of Flamma Innovation, said, “The opening of a cGMP kilo lab not only increases capabilities of our facility but also allows our customers greater flexibility in working with Flamma. The ability to place projects in Italy or China and knowing that Flamma is actively managing all our sites is comforting to our customer base.”
 
Flamma will also begin construction of its new R&D building at our headquarters in Chignolo later this year. “This will quadruple our R&D space thus allowing to continue to grow our staff of researchers to serve the pharma industry and the demands of our current customers as well as future customers,” noted Kenneth Drew, Ph.D., Sr. Director North America Sales and Business Development. “The additional benefit of this addition is the ability to have a fully dedicated analytical building for our growing quality team.”